SERPINB2 and COVID-19: Compared to alteplase, tenecteplase also has increased resistance to PAI-1, a plasminogen activator inhibitor that plays a role in fibrinolytic activity and has been demonstrated to be increased in patients infected with COVID-19 compared to healthy controls and those with other forms of respiratory infection [13].